Jingjing Wang is a Vice President at Lightstone Ventures evaluating biopharma investments. She has a background in neurobiology and life sciences strategy, including consulting at L.E.K. Consulting.
At firms with a similar stage, sector and check size.

One email when Jingjing's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJingjing Wang is a Vice President at Lightstone Ventures evaluating biopharma investments. She has a background in neurobiology and life sciences strategy, including consulting at L.E.K. Consulting.
Lightstone Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Lightstone Ventures backed works best.
Senior Fellow at Office for Translation & Commercialization at Duke University; Life Sciences Consultant at L.E.K. Consulting.
Last updated 2026-10-15. Is this you? Ask for a correction.